Patient views on blood‐based biomarker tests for Alzheimer's disease in primary care

Key Points

• To evaluate patient perspectives on blood-based biomarker tests for Alzheimer's disease in primary care settings.
• Educated primary care patients about biomarker testing
• Assessed willingness to undergo testing
• Evaluated support needs after positive results
• Patients generally showed a willingness to undergo biomarker testing
• Support for the use of testing was expressed
• Informational and psychological support may be needed after a positive test result

Abstract